Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs
about
Potential for developing purinergic drugs for gastrointestinal diseasesNSAID-induced acute phase response is due to increased intestinal permeability and characterized by early and consistent alterations in hepatic gene expressionPrevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategiesFaecal blood loss with aspirin, nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors: systematic review of randomized trials using autologous chromium-labelled erythrocytes.Efficacy, tolerability, and safety of an oral enzyme combination vs diclofenac in osteoarthritis of the knee: results of an individual patient-level pooled reanalysis of data from six randomized controlled trialsEffects of aspirin on gastroduodenal permeability in alcoholics and controlsNonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage.Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?Long-term use of aspirin and the risk of gastrointestinal bleeding.Multiple ileal perforations due to regular diclofenac sodium injections: a case report.Human Intestinal Barrier Function in Health and DiseaseDetermining small bowel integrity following drug treatment.Intestinal permeability in patients after surgical trauma and effect of enteral nutrition versus parenteral nutritionSignificance of a novel sucrose permeability test using serum in the diagnosis of early gastric cancerSystematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs.Nonsteroidal anti-inflammatory drug-induced visible and invisible small intestinal injury(13) C mannitol as a novel biomarker for measurement of intestinal permeabilityReview of the cardiovascular safety of COXIBs compared to NSAIDS.Managing the adverse effects of nonsteroidal anti-inflammatory drugs.Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression.Epithelia under metabolic stress perceive commensal bacteria as a threat.The impact of acid suppression medications and non-steroidal anti-inflammatory drugs on clinical and histologic features in celiac disease.Monitoring Intravenous Abuse of Methadone or Buprenorphine in Opiate Maintenance Treatment (OMT): A Simple and Fast LC-MS-MS Method for the Detection of Disaccharides in Urine Samples.Intestinal mucosal dysfunction and infection during remission-induction therapy for acute myeloid leukaemia.Kinetic analysis of 5 sugar probes in dog serum after orogastric administration.Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury.Alterations in L-Histidine Transport in-Response to Aspirin- and Nimesulide-Induced Toxicity in Rat Intestine Using Everted Intestinal Sacs.Intravenous methadone application as a serious risk factor for an overdose death: methadone-related fatalities in Hamburg from 2007 to 2012.In vivo influence of nicotine on human basal and NSAID-induced gut barrier function.An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia.Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism.Evaluation of a triple sugar test of colonic permeability in humans.Non-steroidal anti-inflammatory drug-induced enteropathy.Indomethacin disrupts the protective effect of phosphatidylcholine against bile salt-induced ileal mucosa injury.The effect of aspirin and smoking on urinary excretion profiles of lactulose and mannitol in young women: toward a dynamic, aspirin augmented, test of gut mucosal permeability.Effect of naproxen on gastric acid secretion and gastric pH.Barrier function of the gut and multiple organ dysfunction after cardiac surgery.
P2860
Q27000719-41BCED6B-60CD-4F2E-AC18-D8FF214F60BAQ28196811-5D29CC9B-C567-4BCF-8489-C054F3987BA6Q28200569-4E2FA265-A866-4061-8700-640851C8090BQ30481876-6B49DC24-5A4B-495E-96D6-4D8D5A301AD5Q31142712-18668C0C-2A62-4EC1-954C-F494997171BBQ34101529-14D1D692-B265-414A-8CAF-564237614930Q34387174-49D9610F-0ABC-4179-937C-40591FE53A1CQ34565398-6456910D-5C82-41C1-A2DF-A73F13CA2B76Q34628874-0E290F1B-2798-4F3C-AB16-68B565093918Q34645031-5735B8C6-4B5F-4E3F-B7EE-9EDBEC9D5DF7Q34679342-E1EE577B-78E7-427F-B3FA-884B13361111Q35200057-3783889F-2287-4609-85C9-9B708078DAB3Q36179014-D9154431-0757-4494-964E-DD3198B26918Q36474459-E0236C67-210A-42C8-A674-5A24416FE97FQ36570803-2EC70F77-BB78-470A-9A14-955BB0339772Q36993530-02C6EEB4-F7C0-49A6-B66D-1105B51CBEF0Q37037330-4EDA6911-B650-450A-8BA7-C3E248710ACBQ37178937-F1B7C314-3761-4C74-8300-81F68085AC8CQ37960540-68F64EAC-5734-431C-9FCF-C5EC9B5B361BQ38024740-1FE35A7C-A0B7-4ED8-A595-50B0073ED85FQ38722151-152740F7-00D5-40DD-816A-86498B09A85AQ38809551-F6400CE0-4C22-461B-8109-53D0BE17E6B9Q38994445-AA9AA478-F882-42A8-B3C2-7288D8C6BCB9Q40273088-8C66B36D-3D7E-4233-80EF-DC7992B50958Q41770258-7B154577-ADDD-493D-9ECA-F1BBD4CC7003Q43010967-CBCB229E-C151-4E5E-B614-0D1416793165Q43215741-6A2D8C32-8180-4A13-A4CF-157FF8FEF265Q43660554-B94BE07E-BD1D-4AD4-9215-F3698F214FCDQ44435838-C6501A92-143B-4AB3-BBB0-90475DBE2167Q44465348-9052A14F-2455-4AE9-841D-181FBE890667Q44572735-46259D8A-F940-4F76-8E71-A63919F22A8CQ45079523-98A2CEF3-73B7-4CE4-B2BF-D64BEAEB977FQ45400230-FE5A101E-483A-44F4-85C3-40E979C3B1C1Q46911139-C768709F-1877-42F0-A101-3283F1BAC6EFQ51327931-97C1C009-80F3-4BB4-BCC4-757E18E54214Q51495341-E19C026E-3A77-4066-8FAE-FA47D6AE0EA9Q52926686-AB5BB06F-E81C-4842-A2F7-CD1E6B64570A
P2860
Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Acute gastrointestinal permeab ...... roidal anti-inflammatory drugs
@ast
Acute gastrointestinal permeab ...... roidal anti-inflammatory drugs
@en
Acute gastrointestinal permeab ...... roidal anti-inflammatory drugs
@nl
type
label
Acute gastrointestinal permeab ...... roidal anti-inflammatory drugs
@ast
Acute gastrointestinal permeab ...... roidal anti-inflammatory drugs
@en
Acute gastrointestinal permeab ...... roidal anti-inflammatory drugs
@nl
prefLabel
Acute gastrointestinal permeab ...... roidal anti-inflammatory drugs
@ast
Acute gastrointestinal permeab ...... roidal anti-inflammatory drugs
@en
Acute gastrointestinal permeab ...... roidal anti-inflammatory drugs
@nl
P2093
P2860
P3181
P356
P1433
P1476
Acute gastrointestinal permeab ...... roidal anti-inflammatory drugs
@en
P2093
J Meddings
S Niveloni
S Pedreira
P2860
P3181
P356
10.1136/GUT.49.5.650
P407
P577
2001-11-01T00:00:00Z